Haloperidol dose for the acute phase of schizophrenia

  • Donnelly L
  • Waraich P
  • Adams C
  • et al.
N/ACitations
Citations of this article
19Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Haloperidol is a benchmark, accessible antipsychotic against which the effects of newer treatments are gauged.

Cite

CITATION STYLE

APA

Donnelly, L., Waraich, P. S., Adams, C. E., Hamill, K. M., Marti, J., Roqué i Figuls, M., & Rathbone, J. (2002). Haloperidol dose for the acute phase of schizophrenia. In Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd. https://doi.org/10.1002/14651858.cd001951

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free